MATTHEW BENZ, MD
Ophthalmology Physician · BELLAIRE, TX
Individual Active NPI 1689771545
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,210 | 34,260 | $24,730,899 | $7,663,719 | $6,068,934 |
| 2023 | 1,184 | 23,250 | $22,617,233 | $7,216,558 | $5,702,996 |
| 2022 | 1,245 | 18,215 | $13,181,877 | $6,582,384 | $5,202,454 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 12,360 | $147 | $117 |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 4,500 | $32 | $25 |
| J0178 | Injection, aflibercept, 1 mg | 3,424 | $821 | $654 |
| 92134 | Imaging of retina | 3,085 | $42 | $32 |
| J0177 | Injection, aflibercept hd, 1 mg | 3,048 | $332 | $265 |
| 67028 | Injection of drug into eye | 2,407 | $142 | $109 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,974 | $230 | $183 |
| 92014 | Established patient complete exam of visual system | 1,832 | $130 | $94 |
| J2778 | Injection, ranibizumab, 0.1 mg | 354 | $141 | $113 |
| 92250 | Photography of the retina | 238 | $37 | $28 |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 205 | $166 | $132 |
| J3590 | Unclassified biologics | 181 | $2,646 | $2,105 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | L6290 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | L6290 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1154438927
- NPI 1124237300
- NPI 1366445645
- NPI 1154777969
- NPI 1598296246
- NPI 1952922494
- NPI 1245761972
- NPI 1205011780
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.